Hechen Huang

601 total citations
11 papers, 422 citations indexed

About

Hechen Huang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hechen Huang has authored 11 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Hechen Huang's work include Phagocytosis and Immune Regulation (2 papers), Ubiquitin and proteasome pathways (2 papers) and Immunotherapy and Immune Responses (2 papers). Hechen Huang is often cited by papers focused on Phagocytosis and Immune Regulation (2 papers), Ubiquitin and proteasome pathways (2 papers) and Immunotherapy and Immune Responses (2 papers). Hechen Huang collaborates with scholars based in China and Madagascar. Hechen Huang's co-authors include Shengyong Yin, Shusen Zheng, Lin Zhou, Xingxing Gao, Caixu Pan, Tianchi Chen, Haiyang Xie, Yuan Zhou, Jianwen Jiang and Junfang Ji and has published in prestigious journals such as Journal of Hepatology, Cancers and Frontiers in Oncology.

In The Last Decade

Hechen Huang

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hechen Huang China	9	210	146	127	80	77	11	422
Hanzhang Zhu China	11	180 0.9×	103 0.7×	87 0.7×	78 1.0×	60 0.8×	18	377
Changku Jia China	10	238 1.1×	115 0.8×	81 0.6×	55 0.7×	73 0.9×	22	427
Wenhua You China	7	239 1.1×	144 1.0×	117 0.9×	51 0.6×	76 1.0×	12	442
Jiuliang Yan China	11	133 0.6×	139 1.0×	113 0.9×	73 0.9×	45 0.6×	18	351
Kailiang Zhao China	10	182 0.9×	117 0.8×	54 0.4×	54 0.7×	41 0.5×	38	354
Siyu Tan China	13	262 1.2×	154 1.1×	220 1.7×	55 0.7×	89 1.2×	29	548
Harshul Pandit United States	10	200 1.0×	133 0.9×	72 0.6×	27 0.3×	89 1.2×	22	411
Jia Hou China	12	126 0.6×	64 0.4×	78 0.6×	46 0.6×	79 1.0×	33	338
Simon Milette Canada	10	159 0.8×	146 1.0×	107 0.8×	44 0.6×	39 0.5×	14	392
Yihang Gong China	11	179 0.9×	131 0.9×	130 1.0×	31 0.4×	58 0.8×	23	461

Countries citing papers authored by Hechen Huang

Since Specialization

Citations

This map shows the geographic impact of Hechen Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hechen Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hechen Huang more than expected).

Fields of papers citing papers by Hechen Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hechen Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hechen Huang. The network helps show where Hechen Huang may publish in the future.

Co-authorship network of co-authors of Hechen Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Hechen Huang. A scholar is included among the top collaborators of Hechen Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hechen Huang. Hechen Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Huang, Hechen, et al.. (2026). HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications. Clinical and Experimental Medicine. 26(1). 148–148.

Wang, Shuai, Qinchuan Wu, Tianchi Chen, et al.. (2022). Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model. Journal of Hepatology. 77(2). 467–478. 109 indexed citations

Gao, Xingxing, Hechen Huang, Caixu Pan, et al.. (2022). Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma. Cancers. 14(19). 4715–4715. 54 indexed citations

Su, Rong, Hechen Huang, Xingxing Gao, et al.. (2022). A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors. Open Medicine. 17(1). 317–328. 4 indexed citations

Gao, Xingxing, Hechen Huang, Yubo Wang, et al.. (2021). Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses. Frontiers in Oncology. 10. 610513–610513. 24 indexed citations

Huang, Hechen, Zhigang Ren, Xingxing Gao, et al.. (2020). Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Medicine. 12(1). 102–102. 126 indexed citations

Hu, Xiaoyi, Junjie Chen, Hechen Huang, et al.. (2020). Syndecan-4 promotes vascular beds formation in tissue engineered liver via thrombospondin 1. Bioengineered. 11(1). 1313–1324. 9 indexed citations

Chen, Tianchi, Lingfeng Zhou, Yuan Zhou, et al.. (2019). HJURP Promotes Epithelial-to-Mesenchymal Transition via Upregulating SPHK1 in Hepatocellular Carcinoma. International Journal of Biological Sciences. 15(6). 1139–1147. 23 indexed citations

Chen, Tianchi, Hechen Huang, Yuan Zhou, et al.. (2018). HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways. Journal of Experimental & Clinical Cancer Research. 37(1). 193–193. 55 indexed citations

10.

Ye, Yufu, Junjun Jia, Zhentao Yang, et al.. (2018). Galectin-1-induced tolerogenic dendritic cells combined with apoptotic lymphocytes prolong liver allograft survival. International Immunopharmacology. 65. 470–482. 10 indexed citations

11.

Huang, Hechen, Tianchi Chen, Yuan Zhou, et al.. (2018). RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma. International Journal of Medical Sciences. 15(14). 1648–1657. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact